Medical Opinion publishes expert perspectives on clinical care, public health, policy, and technology. Each essay is clearly labeled as commentary, discloses conflicts, and cites key evidence.
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Here in Boston, yesterday was the hottest spring day in over a
World Health Organization officials on Wednesday mounted a defense of their response to the new and worrisome Ebola outbreak centered in the Democratic Republic of the Congo, after U.S. Secretary of State
WASHINGTON — A group of Senate Democrats is proposing that Medicare cover in-home care, which would create the first new benefit in the program since the Part D retail drug benefit more
23andMe plans to give its customers the capacity to import their medical records, allowing what it calls “a 360-degree view of their personal health.” The offering will include an AI-written 23andMe Health
WASHINGTON — For years, the United States has poured hundreds of millions of dollars into programs to prevent and control infectious diseases in the Democratic Republic of the Congo. But in the
SAN FRANCISCO — In the first, tenuous weeks of her life, Jorie Kraus and her parents faced her possible death repeatedly. Muscles throughout her tiny body simply didn’t work properly. Her heart.
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Would
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. STAT’s Breakthrough Summit West is today! It’s not too late to attend
The idea of drinking during pregnancy sounds like a generational punchline: Someone’s grandmother drank beer to fatten her fetus, another had a nightly martini to get a healthy amount of sleep — presumably
The Maryland Prescription Drug Affordability Board agreed to set an upper payment limit for the Ozempic diabetes treatment, marking the second time that the state panel has taken such a step in